JPMorgan Chase & Co. is a leading global financial services firm that provides a wide range of financial solutions to consumers, businesses, and governments. The company offers investment banking, asset management, private banking, and wealth management services while also delivering a full suite of commercial banking products. With a strong emphasis on innovation and technology, JPMorgan Chase plays a pivotal role in the financial market, helping clients navigate complex financial landscapes through expert advice and tailored services. The firm is committed to maintaining its reputation for integrity and professionalism while actively contributing to economic development and community investment. Read More
Adient (NYSE:ADNT) executives said the automotive seating supplier expects to finish fiscal 2026 in line with commitments and enter fiscal 2027 with continued revenue growth, improving business performance and margin expansion, supported by Americas onshoring wins, China growth and automation invest
General Motors (NYSE:GM) Chief Financial Officer Paul Jacobson said the automaker’s first half performed “remarkably well,” supporting an increase in full-year guidance, while cautioning that the second half faces pressures from commodity inflation, onshoring costs and vehicle launch activity.
Spea
Doug Petno, Co-President of JPMorganChase and CEO of the Commercial & Investment Bank, will present at the Barclays Global Financial Services Conference in New York City on Tuesday, September 15, 2026 at 2:45 p.m. (Eastern).
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 144% in the afternoon session after its personalized mRNA cancer vaccine, develop...
Anthropic's revenue run rate topped $65 billion after a confidential S-1 filing, and investors can gain indirect exposure via partners like Salesforce, Amazon, Alphabet, SAP, Zoom, and Broadcom.
What Happened? Shares of personal care and home fragrance retailer Bath & Body Works (NYSE:BBWI) jumped 7% in the afternoon session after Citi upgraded the c...
What Happened? A number of stocks fell in the morning session after the latest industrial production report showed slower-than-expected growth for July. Data...
TTM Technologies (NASDAQ:TTMI) said it has agreed to acquire Epiq Solutions in an all-cash transaction valued at $1.1 billion, expanding its radio-frequency and digital signal processing capabilities for aerospace, defense and communications applications.
The company expects the transaction to clos
RALEIGH, N.C. - August 18th, 2026 - Biotech venture capital funding is having a strong year on paper — but K-38 Consulting says founders should look past the headline numbers before drawing conclusions about their own fundraising prospects. Biotech companies collectively raised more than $9.1 billion in venture capital in the first half of 2026, the strongest first-half total since 2022, according to BioPharma Dive data. At the same time, early-stage financing has fallen to its weakest pace since before the pandemic: J.P. Morgan’s first-quarter 2026 biopharma report tracked just 50 seed and Series A investments worth a combined $2.3 billion, down from 60 deals worth $3.7 billion in the same period of 2025.
Gentherm (NASDAQ:THRM) outlined plans to diversify beyond light-vehicle thermal comfort products, expand margins and complete its combination with Modine Performance Technologies, which management expects to close in early fourth quarter.
Speaking at a JPMorgan event, President and CEO Bill Presley
